Pluristem Therapeutic News

PLURISTEM THERAPEUTICS INC Financials

3 Healthcare Stock Stories For Monday Investment Wellness

Pluristem Therapeutics' PLX cells may be effective in treating preeclampsia

Pluristem Announces Preclinical Research Shows PLX Cells May be Effective in Treating Preeclampsia

Preclinical Research Shows PLX Cells May be Effective in Treating Preeclampsia

HAIFA, Israel -- Pluristem Therapeutics Inc. , a leading developer of placenta-based cell therapies, announced today its PLacental eXpanded (PLX) cells tested in preclinical animal models of preeclampsia ...

PLURISTEM THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report

Pluristem Therapeutics announces Phase 1 trial to study PLX-PAD cells

Pluristem Carving Out Distinct Niche in Orthopedic Medicine With New Clinical Trials in Rotator Cuff Repair

Pluristem recently announced a new Phase I trial to check safety and evaluate effectiveness of its PLX-PAD cells in chronic tendonitis often leading to rotator cuff disorders, common in tennis players ...

Pluristem Announces First Clinical Indication for PLX-RAD Cells for Use in Hematology

Pluristem Develops PLX-RAD Cells for Use in Hematology

HAIFA, Israel -- Pluristem Therapeutics Inc. , a leading developer of placenta-based cell therapies, announced today that it has identified its first clinical indication in the hematology field for its ...

U.S. judge gives onetime 'King of Biotech' four years in prison

United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy

Pluristem to Present at Needham Healthcare and Oppenheimer Israeli Investment Conferences in May 2013

HAIFA, Israel -- Pluristem Therapeutics Inc. , a leading developer of placenta-based cell therapies, announced today the company is scheduled to participate in the following investment conferences in May ...

Pluristem's PLX-PAD Cells' safety in human lung models shown by research study

Third Party Research Study Demonstrates Pluristem’s PLX-PAD Cells’ Safety in Human Lung Models of Pulmonary Hypertension

Third Party Research Study Demonstrates Pluristem's PLX-PAD Cells' Safety in Human Lung Models of Pulmonary Hypertension Findings presented at ISHLT meeting in Montreal HAIFA, Israel April 29, 2013 - Pluristem ...